140 related articles for article (PubMed ID: 21124027)
1. KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine.
Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Mori-Iwamoto S; Maehara S; Maehara Y; Sakaida I; Nakamura K
Chemotherapy; 2011; 57(1):12-6. PubMed ID: 21124027
[TBL] [Abstract][Full Text] [Related]
2. Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.
Tokunaga M; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
Anticancer Res; 2015 Nov; 35(11):6063-7. PubMed ID: 26504030
[TBL] [Abstract][Full Text] [Related]
3. Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells.
Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
Anticancer Res; 2010 Jul; 30(7):2539-43. PubMed ID: 20682980
[TBL] [Abstract][Full Text] [Related]
4. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.
Suenaga S; Kuramitsu Y; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
Anticancer Res; 2014 Jan; 34(1):141-6. PubMed ID: 24403454
[TBL] [Abstract][Full Text] [Related]
5. High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells.
Kuramitsu Y; Wang Y; Kitagawa T; Tokuda K; Akada J; Tokunaga M; Nakamura K
Anticancer Res; 2015 Jul; 35(7):3861-5. PubMed ID: 26124331
[TBL] [Abstract][Full Text] [Related]
6. Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells.
Suenaga S; Kuramitsu Y; Wang Y; Baron B; Kitagawa T; Akada J; Tokuda K; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
Anticancer Res; 2013 Nov; 33(11):4821-6. PubMed ID: 24222118
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer Cells.
Shimada T; Nanimoto Y; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
In Vivo; 2018; 32(4):759-763. PubMed ID: 29936456
[TBL] [Abstract][Full Text] [Related]
8. Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.
Mori-Iwamoto S; Kuramitsu Y; Ryozawa S; Mikuria K; Fujimoto M; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
Int J Oncol; 2007 Dec; 31(6):1345-50. PubMed ID: 17982661
[TBL] [Abstract][Full Text] [Related]
9. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y
Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594
[TBL] [Abstract][Full Text] [Related]
10. The Effects of HSP27 on Gemcitabine-Resistant Pancreatic Cancer Cell Line Through Snail.
Zhang S; Zhang XQ; Huang SL; Chen M; Shen SS; Ding XW; Lv Y; Zou XP
Pancreas; 2015 Oct; 44(7):1121-9. PubMed ID: 26348464
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells.
Kuramitsu Y; Suenaga S; Wang Y; Tokuda K; Kitagawa T; Tanaka T; Akada J; Maehara S; Maehara Y; Nakamura K
Anticancer Res; 2013 Aug; 33(8):3133-6. PubMed ID: 23898070
[TBL] [Abstract][Full Text] [Related]
12. Heat-shock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells.
Kuramitsu Y; Wang Y; Taba K; Suenaga S; Ryozawa S; Kaino S; Sakaida I; Nakamura K
Anticancer Res; 2012 Jun; 32(6):2295-9. PubMed ID: 22641665
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma down-regulates heat shock protein 27 of pancreatic cancer cells and helps in the cytotoxic effect of gemcitabine.
Mori-Iwamoto S; Taba K; Kuramitsu Y; Ryozawa S; Tanaka T; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
Pancreas; 2009 Mar; 38(2):224-6. PubMed ID: 19238023
[No Abstract] [Full Text] [Related]
14. Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
Kuramitsu Y; Taba K; Ryozawa S; Yoshida K; Zhang X; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
Anticancer Res; 2010 Sep; 30(9):3367-72. PubMed ID: 20944110
[TBL] [Abstract][Full Text] [Related]
15. Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells.
Kang D; Choi HJ; Kang S; Kim SY; Hwang YS; Je S; Han Z; Kim JH; Song JJ
Cell Signal; 2015 Apr; 27(4):807-17. PubMed ID: 25615626
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells.
Nakashima M; Adachi S; Yasuda I; Yamauchi T; Kawaguchi J; Itani M; Yoshioka T; Matsushima-Nishiwaki R; Hirose Y; Kozawa O; Moriwaki H
Cancer Lett; 2011 Dec; 313(2):218-25. PubMed ID: 21999932
[TBL] [Abstract][Full Text] [Related]
17. Comparative proteomic analysis of two stress-management strategies in pancreatic cancer.
Baron B; Fujioka T; Kitagawa T; Maehara S; Maehara Y; Nakamura K; Kuramitsu Y
Cancer Genomics Proteomics; 2015; 12(2):83-7. PubMed ID: 25770192
[TBL] [Abstract][Full Text] [Related]
18. Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses.
Liu QH; Zhao CY; Zhang J; Chen Y; Gao L; Ni CY; Zhu MH
Mol Med Rep; 2012 Oct; 6(4):767-73. PubMed ID: 22858734
[TBL] [Abstract][Full Text] [Related]
19. Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action.
Baron B; Wang Y; Maehara S; Maehara Y; Kuramitsu Y; Nakamura K
Anticancer Res; 2015 Apr; 35(4):1941-9. PubMed ID: 25862846
[TBL] [Abstract][Full Text] [Related]
20. Heat Shock Protein 27 Expression in EUS-FNA Samples Can Predict Gemcitabine Sensitivity in Pancreatic Cancer.
Kawano M; Kaino S; Amano S; Shinoda S; Suenaga S; Sen-Yo M; Sakaida I
In Vivo; 2018; 32(3):637-642. PubMed ID: 29695571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
